LeXis gene therapy (University of California Los Angeles/Hughes Medical Institute)

N/A

Report date: 2025/03/20 15:07:08

Base Information

Drug NameLeXis gene therapy (University of California Los Angeles/Hughes Medical Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionLiver X receptor modulators
TargetsLiver X receptor
Therapy Area/IndicationsHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesHoward Hughes Medical InstituteUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemia Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A